Ask AI
ProCE Banner Series

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

Gain expert insight on current best practices and emerging strategies for first-line and subsequent treatment of myelofibrosis in these interactive, expert led 1-hour CME/CNE/CPE-certified workshops.

  AAPA
  | ACPE
  | ACPE
  | AMA
  | ANCC
Credits Available

1.0

All Events

Past Events

April

05

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

2:00 PM - 3:00 PM Central Time (CT)

Virtual

Private Event, Mobile, Alabama

April

18

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

7:00 PM - 8:00 PM Pacific Time (PT)

Virtual

Private Event | Fremont, Fremont, California

April

21

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

4:00 PM - 5:00 PM Eastern Time (ET)

In-person

Quality Cancer Care Alliance (QCCA) | Session 1 - 4:00 PM, Atlanta, Georgia

April

21

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges  

5:00 PM - 6:00 PM Eastern Time (ET)

In-person

Quality Cancer Care Alliance (QCCA) | Session 2 - 5:00 PM, Atlanta, Georgia

April

26

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

4:00 PM - 5:00 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group OK, Norman, Oklahoma

April

29

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

10:05 AM - 11:05 AM Eastern Time (ET)

Virtual

Private Event | Virtual, Virtual

May

08

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

12:00 PM - 1:00 PM Central Time (CT)

Virtual

Private Event | Virtual, Amarillo, Texas

May

09

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

5:00 PM - 6:00 PM Eastern Time (ET)

Virtual

Private Event | Host Group Newport News, Newport News, Virginia

June

29

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

12:30 PM - 1:30 PM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group Rockville, Rockville, Maryland

July

06

2023

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenges

11:30 AM - 12:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX, Decatur, Texas

Topics

A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Current Therapeutic Challenge

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, confidence, competence, and performance of learners in the use of evidence-based and guideline-directed best practices in the care of patients with MF.

 

Target Audience
This program is intended for community-based medical hematologists/oncologists, advanced practice providers, nurses, pharmacists, physician assistants/physician associates, and other healthcare professionals involved in the treatment of patients with myelofibrosis. 

 

Learning Objectives:

  • Plan first line therapy for patients with MF based on available data and expert recommendations, taking risk stratification, platelet counts, and symptom burden into account
  • Recognize the symptoms and patterns of suboptimal first line treatment response in patients with MF, including treatment intolerance and treatment resistance
  • Plan evidence-based therapeutic strategies for patients with MF and a suboptimal response to first-line JAK inhibitor therapy
  • Integrate supportive care plans into practice designed to monitor and manage treatment-related toxicities from new or novel MF treatments

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity will be 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-030-L01-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from CTI BioPharma Corp, GSK, and Incyte Corporation.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191